Skip to main page content
U.S. flag
See More

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 23;28(4):1050-1062.e6.
doi: 10.1016/j.celrep.2019.06.078.

Translational Regulation of Non-autonomous Mitochondrial Stress Response Promotes Longevity

Jianfeng Lan  1 , Jarod A Rollins  2 , Xiao Zang  1 , Di Wu  1 , Lina Zou  1 , Zi Wang  1 , Chang Ye  1 , Zixing Wu  1 , Pankaj Kapahi  3 , Aric N Rogers  4 , Di Chen  5
Affiliations

Translational Regulation of Non-autonomous Mitochondrial Stress Response Promotes Longevity

Jianfeng Lan et al. Cell Rep. .

Abstract

Reduced mRNA translation delays aging, but the underlying mechanisms remain underexplored. Mutations in both DAF-2 (IGF-1 receptor) and RSKS-1 (ribosomal S6 kinase/S6K) cause synergistic lifespan extension in C. elegans. To understand the roles of translational regulation in this process, we performed polysomal profiling and identified translationally regulated ribosomal and cytochrome c (CYC-2.1) genes as key mediators of longevity. cyc-2.1 knockdown significantly extends lifespan by activating the intestinal mitochondrial unfolded protein response (UPRmt), mitochondrial fission, and AMP-activated kinase (AMPK). The germline serves as the key tissue for cyc-2.1 to regulate lifespan, and germline-specific cyc-2.1 knockdown non-autonomously activates intestinal UPRmt and AMPK. Furthermore, the RNA-binding protein GLD-1-mediated translational repression of cyc-2.1 in the germline is important for the non-autonomous activation of UPRmt and synergistic longevity of the daf-2 rsks-1 mutant. Altogether, these results illustrate a translationally regulated non-autonomous mitochondrial stress response mechanism in the modulation of lifespan by insulin-like signaling and S6K.

Keywords: AMPK; C. elegans; UPR(mt); aging; daf-2 rsks-1; germline; mRNA translation.

PubMed Disclaimer

Conflict of interest statement

DECLARATION OF INTERESTS

The authors declare no competing interests.

Figures

Figure 1.
Figure 1.. Identification of Genes that Are Translationally Regulated in the daf-2 rsks-1 Mutant
(A) Experimental design of the genome-wide translational state analysis. On the left are representative polysome profiles of wild-type N2 and the daf-2 rsks-1 double mutant. The total and translated mRNA fractions were used for the genome-wide transcriptional and translational state analysis, as depicted by the workflow on the right. (B) Cluster of genes differentially expressed in the daf-2 rsks-1 mutant compared with N2. (C) Top Gene Ontology (GO) terms for genes differentially expressed at the translational level in the daf-2 rsks-1 mutant. (D) qRT-PCR of rps-0, rps-3, rpl-5, and rpl-25.2 mRNA levels (median with range) in N2 and the daf-2 rsks-1 mutant based on three biological replicates (not significant [ns], p > 0.05, two-tailed t tests). (E and F) Immunoblots (E) and quantification (F) of RPS-0, RPS-3, RPL-5, RPL-25.2, and tubulin protein levels in N2 and the daf-2 rsks-1 mutant. The ratio of band intensity of ribosomal proteins to tubulin was normalized to N2. Data are represented as mean ± SEM based on three biological replicates (****p < 0.0001, **p < 0.01, two-tailed t tests). See also Table S1.
Figure 2.
Figure 2.. Knockdown of cyc-2.1 Significantly Extends Lifespan by Activating UPRmt and AMPK
(A) Survival curves of the wild-type N2, rsks-1, daf-2, and daf-2 rsks-1 mutant animals treated with control or cyc-2.1 RNAi. (B) Representative photographs of hsp-6p::gfp expression in animals treated with control or cyc-2.1 RNAi. Scale bar, 200 μm. (C) qRT-PCR of hsp-6 (median with range) using RNAs extracted from dissected intestinal tissues of N2 treated with control or cyc-2.1 RNAi based on three biological replicates (****p < 0.0001, two-tailed t test). (D) Survival curves of the atfs-1 deletion mutant treated with control or cyc-2.1 RNAi (p = 0.2355, log-rank test). (E and F) Immunoblots (E) and quantification (F) of phospho-AAK-2 (AMPKα) and actin in N2 animalstreated with control or cyc-2.1 RNAi. Ratio of band intensity of phospho-AAK-2 to actin was normalized to the control RNAi-treated animals. Data are represented as mean ± SEM based on eight biological replicates (**p = 0.0041, two-tailed t test). (G) Survival curves of the aak-2 deletion mutant treated with control or cyc-2.1 RNAi (p = 0.9647, log-rank test). (H and I) Immunoblots (H) and quantification (I) of phospho-AAK-2 and actin in the atfs-1 deletion mutant treated with control or cyc-2.1 RNAi. Data are represented as mean ± SEM based on four biological replicates (ns, p = 0.5239, two-tailed t test). (J) Representative photographs of hsp-6p::gfp expression in aak-2 deletion mutant animals treated with control or cyc-2.1 RNAi. Scale bar, 200 μm. (K) qRT-PCR of hsp-6 (median with range)using RNAs extracted from dissected intestinal tissues of the aak-2 mutant treated with control or cyc-2.1 RNAi based on three biological replicates (****p < 0.0001, two-tailed t test) . See also Table S3.
Figure 3.
Figure 3.. Inhibition of cyc-2.1 in the Germline Extends Lifespan by Cell-Non-autonomous Activation of UPRmt and AMPK in the Intestine
(A) Tissue-specific cyc-2.1 RNAi-induced changes in the mean lifespan relative to the control RNAi treatments. Data are represented as mean ± SEM based on three biological replicates. (B) qRT-PCR of UPRmt markers hsp-6, dnj-10, timm-17, and drp-1 (median with range) using RNAs extracted from dissected gonadal and intestinal tissues of N2 treated with global control or cyc-2.1 RNAi based on three biological replicates (ns, ***p < 0.001, p > 0.05, two-tailed t tests). (C and D) Immunoblots (C) and quantification (D) of phospho-AAK-2 and actin using proteins extracted from dissected gonadal and intestinal tissues of N2 treated with global control or cyc-2.1 RNAi. Data are represented as mean ± SEM based on three biological replicates (ns, **p < 0.01, p = 0.2436, two-tailed t tests). (E) Survival curves of the aak-2 mutant carrying an aak-2 transgene driven by the intestine-specific vha-6 promoter treated with the control or cyc-2.1 RNAi (p < 0.0001, log-rank test). (F) qRT-PCR of UPRmt markers (median with range) using RNAs extracted from dissected intestinal tissues of animals treated with germline- or intestine-specific control versus cyc-2.1 RNAi based on three biological replicates (***p < 0.001, **p < 0.01, *p < 0.05, two-tailed t tests). (G and H) Immunoblots (G) and quantification (H) of phospho-AAK-2 and tubulin using proteins extracted from dissected intestinal tissues of animals treated with germline- or intestine-specific control versus cyc-2.1 RNAi. Data are represented as mean ± SEM based on three biological replicates(ns, **p < 0.001, p = 0.6141, two-tailed t tests). (I) qRT-PCR of UPRmt markers (median with range) using RNAs extracted from dissected intestinal tissues of the cup-4 mutant treated with germline-specific control or cyc-2.1 RNAi based on three biological replicates (ns, *p < 0.05, p > 0.05, two-tailed t tests). (J and K) Immunoblots (J) and quantification (K) of phospho-AAK-2 and tubulin using proteins extracted from dissected intestinal tissues of the cup-4 mutant treated with germline-specific control or cyc-2.1 RNAi. Data are represented as mean ± SEM based on three biological replicates (ns, p = 0.3957, two-tailed t tests). (L) Survival curves of the cup-4 mutant treated with germline-specific control or cyc-2.1 RNAi (p = 0.8629, log-rank test). See also Figure S3 and Table S3.
Figure 4.
Figure 4.. cyc-2.1 Knockdown-Induced Mitochondria Fragmentation Plays an Important Role in AMPK Activation and Lifespan Extension
(A and B) Representative photographs (A) and quantification (B) of intestinal mitochondrial morphology in animals treated with control or cyc-2.1 RNAi (p < 0.0001, χ2 test). Scale bar, 10 μm. (C and D) Immunoblots (C) and quantification (D) of phospho-AAK-2 and actin in N2 and drp-1 mutant animals treated with control or cyc-2.1 RNAi. Data are represented as mean ± SEM based on three biological replicates (ns, *p < 0.05, p = 0.3103, two-tailed t tests). (E) Survival curves of N2 and the drp-1 mutant treated with control or cyc-2.1 RNAi. (F) cyc-2.1 RNAi-induced changes in mean lifespan relative to the control RNAi treatments in N2 and drp-1 mutant backgrounds. Data are represented as mean ± SEM based on three biological replicates (*p < 0.05, two-tailed t test). See also Table S3.
Figure 5.
Figure 5.. Translational Repression of CYC-2.1 in the Germline and Non-autonomous Activation of UPRmt in the Intestine Play an Important Role in Regulating the Synergistic Lifespan Extension by daf-2 rsks-1
(A and B) Immunoblots (A) and quantification (B) of CYC-2.1::3x FLAG and tubulin using proteins extracted from dissected gonadal and intestinal tissues of N2 and daf-2 rsks-1 mutant animals. Data are represented as mean ± SEM based on three biological replicates (ns, **p < 0.01, p = 0.0880, two-tailed t tests). (C) qRT-PCR of UPRmt markers (median with range) using RNAs extracted from dissected gonadal and intestinal tissues of N2 and daf-2 rsks-1 mutant animals based on three biological replicates (ns, ***p < 0.001, **p < 0.01, p > 0.05, two-tailed t tests). (D and E) Survival curves of N2 (D) and the daf-2 rsks-1 mutant (E) treated with the control, dve-1, ubl-5, or atfs-1 RNAi. (F) The daf-2 rsks-1 double mutations induced changes in mean lifespan upon control, dve-1, ubl-5, or atfs-1 RNAi treatment. Data are represented as mean ± SEM based on three biological replicates (***p < 0.001, **p < 0.01, two-tailed t tests). See also Table S3.
Figure 6.
Figure 6.. Translational Repression of cyc-2.1 by GLD-1 Contributes to the UPRmt Activation and Lifespan Extension in the daf-2 rsks-1 Mutant
(A and B) Representative photographs (A) and quantification (B) of GLD-1::mKate2 expression in the germline of N2 and daf-2 rsks-1 mutant animals. Data are represented as mean ± SEM (****p < 0.0001, two-tailed t test). Scale bar, 50 μm. (C and D) Immunoblots (C) and quantification (D) of CYC-2.1::3x FLAG and tubulin using proteins extracted from dissected gonadal and intestinal tissues of N2 and daf-2 rsks-1 mutant animals. Data are represented as mean ± SEM based on three biological replicates (ns, *p < 0.05, p = 0.7063, two-tailed t tests). (E) qRT-PCR of UPRmt markers (median with range) using RNAs extracted from dissected intestinal tissues of the daf-2 rsks-1 mutant treated with the control versus gld-1 RNAi based on three biological replicates (****p < 0.0001, ***p < 0.001, two-tailed t tests). (F) Survival curves of the wild-type N2, rsks-1, daf-2, and daf-2 rsks-1 mutant animals treated with control or gld-1 RNAi. (G) Model depicting the translational repression of CYC-2.1 by GLD-1 in the germline non-autonomously activates UPRmt and AMPK in the intestine via germline-produced mitokine (gMitokine) signaling, which leads to significant lifespan extension in the daf-2 rsks-1 mutant. See also Table S3.
See this image and copyright information in PMC

References

    1. Ahier A, Dai C-Y, Tweedie A, Bezawork-Geleta A, Kirmes I, and Zuryn S (2018). Affinity purification of cell-specific mitochondria from whole animals resolves patterns of genetic mosaicism. Nat. Cell Biol 20, 352–360. - PubMed
    1. Anders S, Pyl PT, and Huber W (2015). HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169. - PMC - PubMed
    1. Baruah A, Chang H, Hall M, Yuan J, Gordon S, Johnson E, Shtessel LL, Yee C, Hekimi S, Derry WB, and Lee SS (2014). CEP-1, the Caenorhabditis elegans p53 homolog, mediates opposing longevity outcomes in mitochondrial electron transport chain mutants. PLoS Genet. 10, e1004097. - PMC - PubMed
    1. Beanan MJ, and Strome S (1992). Characterization of a germ-line proliferation mutation in C. elegans. Development 116, 755–766. - PubMed
    1. Benjamin Y, and Hochberg Y (1995). Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B 57, 289–300.

Publication types

MeSH terms

Substances